Literature DB >> 16452668

The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.

Trent D Lund1, Laura R Hinds, Robert J Handa.   

Abstract

Estrogen receptor beta (ERbeta) and androgen receptor (AR) are found in high levels within populations of neurons in the hypothalamus. To determine whether AR or ERbeta plays a role in regulating hypothalamo-pituitary-adrenal (HPA) axis function by direct action on these neurons, we examined the effects of central implants of 17beta-estradiol (E2), 5alpha-dihydrotestosterone (DHT), the DHT metabolite 5alpha-androstan-3beta, 17beta-diol (3beta-diol), and several ER subtype-selective agonists on the corticosterone and adrenocorticotropin (ACTH) response to immobilization stress. In addition, activation of neurons in the paraventricular nucleus (PVN) was monitored by examining c-fos mRNA expression. Pellets containing these compounds were stereotaxically implanted near the PVN of gonadectomized male rats. Seven days later, animals were killed directly from their home cage (nonstressed) or were restrained for 30 min (stressed) before they were killed. Compared with controls, E2 and the ERalpha-selective agonists moxestrol and propyl-pyrazole-triol significantly increased the stress induced release of corticosterone and ACTH. In contrast, central administration of DHT, 3beta-diol, and the ERbeta-selective compound diarylpropionitrile significantly decreased the corticosterone and ACTH response to immobilization. Cotreatment with the ER antagonist tamoxifen completely blocked the effects of 3beta-diol and partially blocked the effect of DHT, whereas the AR antagonist flutamide had no effect. Moreover, DHT, 3beta-diol, and diarylpropionitrile treatment significantly decreased restraint-induced c-fos mRNA expression in the PVN. Together, these studies indicate that the inhibitory effects of DHT on HPA axis activity may be in part mediated via its conversion to 3beta-diol and subsequent binding to ERbeta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452668      PMCID: PMC6675494          DOI: 10.1523/JNEUROSCI.3777-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Correlation of in vivo and in vitro activities of some naturally occurring androgens using a radioreceptor assay for 5alpha-dihydrotestosterone with rat prostate cytosol receptor protein.

Authors:  P K Grover; W D Odell
Journal:  J Steroid Biochem       Date:  1975-10       Impact factor: 4.292

2.  Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.

Authors:  V Viau; L Soriano; M F Dallman
Journal:  J Neuroendocrinol       Date:  2001-05       Impact factor: 3.627

3.  Differential expression of nicotinamide adenine dinucleotide phosphate-diaphorase in hypothalamic areas of obese Zucker rats.

Authors:  M J Kim; Y Kim; B K Choe; S A Kim; H J Lee; J W Kim; Y Huh; C Kim; J H Chung
Journal:  Neurosci Lett       Date:  2000-09-29       Impact factor: 3.046

4.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

Authors:  S R Stauffer; C J Coletta; R Tedesco; G Nishiguchi; K Carlson; J Sun; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

5.  Pre- or postnatal testosterone and flutamide effects on sexually dimorphic nuclei of the rat hypothalamus.

Authors:  T D Lund; D L Salyer; D E Fleming; E D Lephart
Journal:  Brain Res Dev Brain Res       Date:  2000-04-14

6.  Brain aromatase in control versus castrated Norway Brown, Sprague-Dawley and Wistar adult rats.

Authors:  L J Mathias; N A Jacobson; R W Rhees; E D Lephart
Journal:  Proc Soc Exp Biol Med       Date:  1999-06

7.  A role for estrogen receptor beta in the regulation of growth of the ventral prostate.

Authors:  Z Weihua; S Makela; L C Andersson; S Salmi; S Saji; J I Webster; E V Jensen; S Nilsson; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

8.  Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.

Authors:  L J Muglia; L Jacobson; C Luedke; S K Vogt; M L Schaefer; P Dikkes; S Fukuda; Y Sakai; T Suda; J A Majzoub
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

9.  Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy.

Authors:  M J Glass; C J Billington; A S Levine
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-07       Impact factor: 3.619

10.  Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variant missing exon 4.

Authors:  R H Price; N Lorenzon; R J Handa
Journal:  Brain Res Mol Brain Res       Date:  2000-09-15
View more
  111 in total

1.  Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.

Authors:  Ali Iranmanesh; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Eur J Endocrinol       Date:  2010-03-18       Impact factor: 6.664

2.  Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

Authors:  Carrie McAllister; Jiangang Long; Adrienne Bowers; Aaron Walker; Philip Cao; Shin-Ichiro Honda; Nobuhiro Harada; Matthias Staufenbiel; Yong Shen; Rena Li
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 3.  Sex differences and stress across the lifespan.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

4.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Géraldine H Petit; Gunnar K Gouras; Patrik Brundin; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-09-25       Impact factor: 4.418

Review 5.  Estrogen receptors and the regulation of neural stress responses.

Authors:  Robert J Handa; Shaila K Mani; Rosalie M Uht
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

Review 6.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

Review 7.  The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation.

Authors:  Damian G Zuloaga; David A Puts; Cynthia L Jordan; S Marc Breedlove
Journal:  Horm Behav       Date:  2008-02-15       Impact factor: 3.587

8.  Sex differences in stress-induced social withdrawal: independence from adult gonadal hormones and inhibition of female phenotype by corncob bedding.

Authors:  Brian C Trainor; Elizabeth Y Takahashi; Katharine L Campi; Stefani A Florez; Gian D Greenberg; Abigail Laman-Maharg; Sarah A Laredo; Veronica N Orr; Andrea L Silva; Michael Q Steinman
Journal:  Horm Behav       Date:  2013-02-04       Impact factor: 3.587

9.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

10.  Human metabolome associates with dietary intake habits among African Americans in the atherosclerosis risk in communities study.

Authors:  Yan Zheng; Bing Yu; Danny Alexander; Lyn M Steffen; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2014-05-06       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.